Israel strikes Gaza during ceasefire, killing about 104 people, including many children and women, in retaliation for the killing of an Israeli soldier.
FDA proposes new guidelines to expedite biosimilar drug approvals, aiming to increase competition, lower prices, and improve patient access to biologic therapies.
Israel strikes Gaza during ceasefire, killing about 104 people, including many children and women, in retaliation for the killing of an Israeli soldier.
FDA proposes new guidelines to expedite biosimilar drug approvals, aiming to increase competition, lower prices, and improve patient access to biologic therapies.